Announcements Trials
Browse Landscape

Phase

Phase NA 90Phase 3 54Phase 2 43Phase 4 39Phase 2/3 11Phase 1/2 9Phase 1 9Phase EARLY_PHASE1 5

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 3Pelvic Neoplasms 1Pancreatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Saline Solution × Clear all
NCT04048278 2025-03-03

Lidocaine Infusion in Pancreatic Cancer

University of Illinois at Chicago

Phase EARLY_PHASE1 Recruiting
46 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04199754 2024-05-31

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Columbia University

Phase EARLY_PHASE1 Terminated
6 enrolled
Gynecologic

Pelvic Neoplasms

NCT04019834 2022-08-03

RELIEF

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed
21 enrolled
Breast

Breast Neoplasms

NCT02806817 2019-07-23

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

Centro Nacional de Investigaciones Oncologicas CARLOS III

Phase EARLY_PHASE1 Completed
40 enrolled
Breast

Breast Neoplasms

NCT02719795 2017-02-17

PNBCP

First Affiliated Hospital Xi'an Jiaotong University

Phase EARLY_PHASE1 Unknown
140 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡